Perception of the COVID-19 Vaccine in the Chilean Population
Percepción de la Vacuna contra la COVID-19 en Población Chilena
Main Article Content
Introduction: The vaccine has proven to be the most effective way to control the COVID-19 pandemic, preventing complications such as severe symptoms and mortality. The decision to be vaccinated and the perception of the vaccine have been influenced by the perception of risk, the media and psychological, sociocultural and biological factors.
Objectives: To identify in the Chilean population the perception of the COVID-19 vaccine, its biopsychosocial factors and the influence of sociodemographic and vaccination-related variables.
Methods: A questionnaire was adapted to obtain an index of perception of the vaccine and it was applied to 695 Chileans. The questionnaire included biological, psychological and sociocultural factors, in addition, sociodemographic questions and questions about the COVID-19 vaccine were asked; association analysis and multiple linear regression were performed.
Results: It was observed that, although 96.3% of the participants are vaccinated against COVID-19, the general perception of the vaccine is regular, with a predominance of the psychological dimension. Variables such as socioeconomic level, the voluntary decision to be vaccinated against COVID-19, the death of someone close to COVID-19 while vaccinated, and the conflict over the decision to be vaccinated are significantly related and influence the perception of the vaccine .
Conclusions: The findings contribute to the vaccination processes. To understand the perception of a vaccine, the biopsychosocial perspective, the perception of risk in relation to health behaviors, the influence of the media and other factors involved must be taken into account.
Downloads
Article Details
Organización Mundial de la Salud. Coronavirus [Internet]. 2019 [consultado 8 de noviembre de 2022]. Disponible en: https://www.who.int/es/health-topics/coronavirus#tab=tab_1
Organización Mundial de la Salud. COVID-19: cronología de la actuación de la OMS [Internet]. 2020 [consultado 27 de noviembre de 2022]. Disponible en: https://www.who.int/es/news/item/27-04-2020-who-timeline---covid-19
Lai C, Shih T, Ko W, Tang H, Hsueh P. Severe acute respiratory síndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J of Antimicrob Agents. 2020;55(3):1-9. https://doi.org/10.1016/j.ijantimicag.2020.105924 DOI: https://doi.org/10.1016/j.ijantimicag.2020.105924
Organización Panamericana de la Salud. Salud Mental y COVID-19 [Internet]. 2021 [consultado 27 de noviembre de 2022]. Disponible en: https://www.paho.org/es/salud-mental-covid-19
Organización Panamericana de la Salud. Respuesta de la OPS a la COVID-19 en la región [Internet]. 2022 [consultado 27 de noviembre de 2022]. Disponible en: https://www.paho.org/en/covid-19/pahos-response-region
Sanchez-Duque LA, Arce-Villalobos LR, Rodríguez-Morales AJ. Enfermedad por coronavirus 2019 (COVID-19) en América Latina: Papel de la atención primaria en la preparación y respuesta. Aten Primaria. 2020; 52(6):369-372. https://doi.org/10.1016%2Fj.aprim.2020.04.001 DOI: https://doi.org/10.1016/j.aprim.2020.04.001
Organización Mundial de la Salud. Vacunas e inmunización ¿Que es la vacunación? [Internet]. 2021 [consultado 30 de noviembre de 2022]. Disponible en: https://www.who.int/es/news-room/questions-and-answers/item/vaccines-and-immunization-what-is-vaccination
Organización Mundial de la Salud. Enfermedad por el coronavirus (COVID-19): Vacunas [Internet]. 2022 [consultado 17 de diciembre de 2022] Disponible en: https://www.who.int/es/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines
García F. Métodos moleculares para el desarrollo de vacunas. Acta pediátr. costarric [Internet]. 1999. [consultado 17 de diciembre 2022]; 13(2):55-59. Disponible en: http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S1409-00901999000200002&lng=en
Taborda AR, Murillo DA, Moreno CL, Taborda PAR, Fuquen M, Díaz PA, et al. Análisis de impacto presupuestal de la vacunación contra COVID-19 en América Latina. Rev Panam Salud Publica. 2022; 46:1. https://doi.org/10.26633/rpsp.2022.5 DOI: https://doi.org/10.26633/RPSP.2022.5
Picazo JJ. Vacuna frente al COVID-19. Rev Esp Quimioter 2021; 34(6):559-598. https://doi.org/10.37201/req/085.2021 DOI: https://doi.org/10.37201/req/085.2021
Eslava-Schmalbach J, Rosero EB, Garzón-Orjuela N. Global control of COVID-19: good vaccines may not suffice. Rev Panam Salud Publica. 2021; 45:e148. https://doi.org/10.26633/RPSP.2021.148 DOI: https://doi.org/10.26633/RPSP.2021.148
Benítez MA, Velasco C, Sequeira AR, Henríquez J, Menezes FM. Responses to COVID-19 in five Latin American countries. Health Policy Technol. 2020; 9(4):525-559. https://doi.org/10.1016/j.hlpt.2020.08.014 DOI: https://doi.org/10.1016/j.hlpt.2020.08.014
Saddik B, Al-Bluwi N, Shukla A, Barqawi H, Alsayed HAH, Sharif-Askari NS, et al. Determinants of healthcare workers perceptions, acceptance and choice of COVID-19 vaccines: a cross-sectional study from the United Arab Emirates. Hum Vaccin Immunother. 2021; 1-9. https://doi.org/10.1080/21645515.2021.1994300 DOI: https://doi.org/10.1080/21645515.2021.1994300
African Union, Africa CDC Centres for Disease Control and Prevention, World Health Organization WHO, et al. COVID 19 Vaccine Perceptions: A 15 country study [Internet]. 2021 [consultado 1 de noviembre de 2022]. CID: 20.500.12592/136t8j. Disponible en: https://africacdc.org/download/covid-19-vaccine-perceptions-a-15-country-study/
National Center for Immunization and Respiratory Diseases (U.S.) Division of Viral Diseases, Centros para el control y la prevención de enfermedades. Mantenerse al día con las vacunas contra el COVID-19, incluidas las dosis de refuerzo [Internet]. 2022 [consultado 8 de noviembre de 2022]. Disponible en: https://espanol.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines.html
Andreu-Sánchez C, Martín-Pascual M. Fake images of the SARS-CoV-2 coronavirus in the communication of information at the beginning of the first Covid-19 pandemic. Prof de la inf. 2020;29(3). https://doi.org/10.3145/epi.2020.may.09 DOI: https://doi.org/10.3145/epi.2020.may.09
Pulido CM, Villarejo-Carballido B, Redondo-Sama G, Gómez A. COVID-19 infodemic: More retweets for science-based information on coronavirus than for false information. Int Sociol. 2020;35(4):377-392. https://doi.org/10.1177/0268580920914755 DOI: https://doi.org/10.1177/0268580920914755
Mullo-López A, de-Casas-Moreno P, Balseca-Mera JM. Tratamiento informativo y competencias mediáticas sobre la COVID-19 en Ecuador. RCom. 2021;20(1):137-52. https://doi.org/10.26441/RC20.1-2021-A8 DOI: https://doi.org/10.26441/RC20.1-2021-A8
Tejada SF, Medina-Neira D. La automedicación promovida por medios de comunicación, un peligro con consecuencias en tiempos de crisis de salud pública por la COVID-19. Rev Cuba Inf En Cienc Salud. [Internet]. 2020 [consultado 1 de noviembre de 2022]; 31(3):e1632. Disponible en: https://www.redalyc.org/articulo.oa?id=377665638006
Quispe-Cañari JF, Fidel-Rosales E, Manrique D, Mascaró-Zan J, Huamán-Castillón KM, Chamorro-Espinoza SE, et al. Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey. Publ Saudi Pharm J Soc. 2021;29(1):1-11. https://doi.org/10.1016/j.jsps.2020.12.001 DOI: https://doi.org/10.1016/j.jsps.2020.12.001
Organización Panamericana de la Salud. Entender la infodemia y la desinformación en la lucha contra la COVID-19 [Internet]. 2020 [consultado 12 de noviembre de 2022]. Disponible en: https://iris.paho.org/bitstream/handle/10665.2/52053/Factsheet-Infodemic_spa.pdf?sequence=16
Crawshaw J, Konnyu K, Castillo G, van Allen Z, Grimshaw JM, Presseau J. Behavioural determinants of COVID-19 vaccination acceptance among healthcare workers: a rapid review. Public Health. 2022; 210:123-133. https://doi.org/10.1016/j.puhe.2022.06.003 DOI: https://doi.org/10.1016/j.puhe.2022.06.003
Sánchez A, Arias-Oliva J, Pelegrín-Borondo M, Rua L. Factores explicativos de la aceptación de la vacuna para el SARS-CoV-2 desde la perspectiva del comportamiento del consumidor. Rev Esp Pública. [Internet]. 2021 [consultado 12 de noviembre de 2022]; 95:28-e202107101. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34267176/
Kishore J, Venkatesh U, Ghai G, Heena-Kumar P. Perception and attitude towards COVID-19 vaccination: A preliminary online survey from India. J Family Med Prim Care. 2021;10(8):3116–21. https://doi.org/10.4103/jfmpc.jfmpc_2530_20 DOI: https://doi.org/10.4103/jfmpc.jfmpc_2530_20
Wake AD. The Willingness to receive COVID-19 vaccine and its associated factors: “vaccination refusal could prolong the war of this pandemic”—a systematic review. RMHP. 2021; 14:2609–23. https://doi.org/10.2147/RMHP.S311074 DOI: https://doi.org/10.2147/RMHP.S311074
Syan SK, Gohari MR, Levitt EE, Belisario K, Gillard J, DeJesus J, et al. COVID-19 vaccine perceptions and differences by sex, age, and education in 1,367 community adults in Ontario. Front Public Health. 2021;9:719665. https://doi.org/10.3389/fpubh.2021.719665 DOI: https://doi.org/10.3389/fpubh.2021.719665
Gurley S, Bennett B, Sullivan PS, Kiley M, Linde J, Szczerbacki D, et al. COVID-19 vaccine perceptions, intentions, and uptake among young adults in the United States: Prospective college-based cohort study. JMIR. 2021;c 15;7(12):e33739. https://doi.org/10.2196/33739 DOI: https://doi.org/10.2196/33739
El-Mohandes A, White TM, Wyka K, Rauh L, Rabin K, Kimball SH, et al. COVID-19 vaccine acceptance among adults in four major US metropolitan areas and nationwide. Sci Rep. 2021;11(1):21844. https://doi.org/10.1038/s41598-021-00794-6 DOI: https://doi.org/10.1038/s41598-021-00794-6
Ramonfaur D, Hinojosa-González DE, Rodriguez-Gomez GP, Iruegas-Nuñez DA, Flores-Villalba E. COVID-19 vaccine hesitancy and acceptance in Mexico: a web-based nationwide survey. Rev Panam Salud Publica. 2021;45:e133. https://doi.org/10.26633/RPSP.2021.133 DOI: https://doi.org/10.26633/RPSP.2021.133
Nouri V, Marte MI, Pichardo E. Percepción de la población sobre la vacuna contra el COVID-19: perspectivas en República Dominicana, 2020. Cienc Salud 2021;5(3):27–35. https://doi.org/10.22206/cysa.2021.v5i3.pp27-35 DOI: https://doi.org/10.22206/cysa.2021.v5i3.pp27-35
Herrera-Añazco P, Uyen-Cateriano Á, Urrunaga-Pastor D, Bendezu-Quispe G, Toro-Huamanchumo CJ, Rodríguez-Morales AJ, et al. Prevalencia y factores asociados a la intención de vacunarse contra la COVID-19 en el Perú. Rev Peru Med Exp Salud Publica. 2021;38(3):381–90. https://doi.org/10.17843/rpmesp.2021.383.7446 DOI: https://doi.org/10.17843/rpmesp.2021.383.7446
Kop WJ. Biopsychosocial processes of health and disease during the COVID-19 pandemic. Psychosom Med. 2021;83(4):304–8. https://doi.org/10.1097/PSY.0000000000000954 DOI: https://doi.org/10.1097/PSY.0000000000000954
Chigangaidze RK. Risk factors and effects of the morbus: COVID-19 through the biopsychosocial model and ecological systems approach to social work practice. Soc Work Public Health. 2021;36(2):98–117. https://doi.org/10.1080/19371918.2020.1859035 DOI: https://doi.org/10.1080/19371918.2020.1859035
Nürnberger P, von Lewinski D, Rothenhäusler H-B, Braun C, Reinbacher P, Kolesnik E, et al. A biopsychosocial model of severe fear of COVID-19. PLoS One. 2022;17(2):e0264357. https://doi.org/10.1371/journal.pone.0264357 DOI: https://doi.org/10.1371/journal.pone.0264357
Ali-Jadoo SA. COVID -19 pandemic is a worldwide typical biopsychosocial crisis. jidhealth. 2020;3(2):152–4. https://doi.org/10.47108/jidhealth.vol3.iss2.58 DOI: https://doi.org/10.47108/jidhealth.Vol3.Iss2.58
Mahasing C, Yasopa O, Sansilapin C, Rattanathumsakul T, Thammawijaya P, Suphanchaimat R, et al. Investigation of a cluster of immunization stress-related reactions after Coronavirus disease 2019 (COVID-19) vaccination, Thailand, 2021. Vaccines (Basel). 2022;10(3). https://doi.org/10.3390/vaccines10030441 DOI: https://doi.org/10.3390/vaccines10030441
Raude J, Debin M, Souty C, Guerrisi C, Turbelin C, Falchi A, et al. Are people excessively pessimistic about the risk of coronavirus infection?. PsyArXiv. [Internet]. 2020. [consultado 12 de noviembre de 2022]. Disponible en: https://doi.org/10.31234/osf.io/364qj DOI: https://doi.org/10.31234/osf.io/364qj
Cavazos-Arroyo J, Pérez de Celis-Herrero C. Severidad, susceptibilidad y normas sociales percibidas como antecedentes de la intención de vacunarse contra COVID-19. Rev. salud pública. 2020;22(2):178-184. https://doi.org/10.15446/rsap.v22n2.86877 DOI: https://doi.org/10.15446/rsap.v22n2.86877
Urzúa A, Villarroel PV, Caqueo A, Polanco R. La Psicología en la prevención y manejo del COVID-19. Aportes desde la evidencia inicial. Ter Psicol. 2020;38(1):103-118. https://doi.org/10.4067/S0718-48082020000100103 DOI: https://doi.org/10.4067/S0718-48082020000100103
Juarez-Najera M, Bustos-Aguayo JM, Carrerón J, García C. La percepción de riesgo en estudiantes universitarios ante la propagación del coronavirus SARS-COV-2 y la enfermedad COVID-19. Rev Psicol UAEM. 2020;9(17): 94-107. https://doi.org/10.36677/rpsicologia.v9i17.15223 DOI: https://doi.org/10.36677/rpsicologia.v9i17.15223
Matar-Khalil S, Ortiz-Barrero MJ, González-Campos J. Diseño y validación de un cuestionario para evaluar la percepción de riesgo de contagio de COVID-19 en población colombiana. Rev Peru Med Exp Salud Publica. 2021;38(4):512–20. https://doi.org/10.17843/rpmesp.2021.384.9298 DOI: https://doi.org/10.17843/rpmesp.2021.384.9298
Colegio de Químicos Farmacéuticos y Bioquímicos de Chile (AG). Chile: Expertos llaman a no automedicarse con cloroquina e hidroxicloroquina [Internet]. 2022 [consultado 8 de diciembre de 2022]. Disponible en: https://www.colegiofarmaceutico.cl/index.php/noticias-nacionales/coronavirus-informate/el-colegio-en-la-prensa/3505-chile-expertos-llaman-a-no-automedicarse-con-cloroquina-e-hidroxicloroquina-por-covid-19
Caserotti M, Girardi P, Rubaltelli E, Tasso A, Lotto L, Gavaruzzi T. Associations of COVID-19 risk perception with vaccine hesitancy over time for Italian residents. Soc Sci Med. 2021;272(113688):113688. https://doi.org/10.1016/j.socscimed.2021.113688 DOI: https://doi.org/10.1016/j.socscimed.2021.113688
Martinelli M, Veltri GA. Do cognitive styles affect vaccine hesitancy? A dual-process cognitive framework for vaccine hesitancy and the role of risk perceptions. Soc Sci Med. 2021;289(114403):114403. https://doi.org/10.1016/j.socscimed.2021.114403 DOI: https://doi.org/10.1016/j.socscimed.2021.114403
Matar-Khalil S, Ortiz-Barrero M, González-Campos J. Percepción de la vacuna contra la COVID-19 en población colombiana. Rev Cubana Farmacia. 2023;56(2). https://revfarmacia.sld.cu/index.php/far/article/view/887
UNICEF 2023. Estado Mundial de la Infancia 2023 [consultado 9 de octubre de 2023]. Disponible en: https://www.unicef.org/chile/documents/estado-mundial-de-la-infancia-2023
MINSAL 2023. Reporte diario COVID-19 [consultado 9 de octubre de 2023]. Disponible en: https://www.minsal.cl/category/reporte-covid-19-diario/
Organización Mundial de la Salud. Vacunas contra la COVID-19 [Internet]. 2019 [consultado 8 de diciembre de 2022]. Disponible en: https://www.who.int/es/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines
Krause PR, Fleming TR, Peto R, Longini IM, Figueroa JP, Sterne JAC, Cravioto A, et al. Considerations in boosting COVID-19 vaccine immune responses. The Lancet. 2021;398:1377-1380. https://doi.org/10.1016/S0140-6736(21)02046-8 DOI: https://doi.org/10.1016/S0140-6736(21)02046-8
Matar-Khalil S, Ortiz Barrero MJ, González-Campos J. Percepción de riesgo de contagio COVID-19 en población colombiana. Revista Salud Publica de Cuba, 2023;26(3). https://revsaludpublica.sld.cu/index.php/spu/article/view/3715